Clin2
NCT06231563Likely a fitRecruiting

Ketamine for depression in veterans with Parkinson's

Parkinson's Disease

Treatments studied

Part of Brain & nervous system clinical trials.

This study tests if ketamine can help treat depression in veterans with Parkinson's disease. It involves several in-person and remote visits, and you will need to avoid certain medications and cannabis for a short time before and during some visits.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
80 people
Ages
40 years to 80 years
Study type
Interventional

Who can take part

  • You are a U.S. military veteran.
  • You are between 40 and 80 years old.
  • You have been diagnosed with Parkinson's disease for at least 6 months.
  • You have tried at least one antidepressant medication that did not help enough.
  • You have moderate or greater symptoms of depression (feeling down most days).
  • Your medications have been stable for at least 2 months, and you are willing to keep them the same during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06402955Recruiting· Phase 2
Imaging depression in Parkinson's disease

This study uses brain imaging (PET scans) to understand depression in people with Parkinson's disease. It may also test a depression treatment called ketamine, but the main goal is to see how the brain changes with depression.

New Haven, Connecticut
NCT06419439Recruiting· Phase 2
Ketamine for Veterans with Chronic Back Pain and Depression

This study tests whether ketamine, combined with talk therapy, can help veterans with both chronic low back pain and depression. The goal is to reduce pain and improve mood.

Ann Arbor, Michigan
NCT05327699Recruiting· Early Phase 1
Ketamine study for depression with reduced pleasure

This early-phase study tests whether ketamine can help people with major depression who have trouble feeling pleasure. It also studies how the brain may change in response to stress, to better understand who might respond to treatment.

Atlanta, Georgia
NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania
NCT06668571Recruiting· Phase 2
Ketamine for treatment-resistant depression

This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.

Rochester, Minnesota
NCT06228391Not yet recruiting· Phase 2
Ketamine for PTSD and Depression after Brain Injury

This study tests whether ketamine can help Veterans with both PTSD and depression who have also had a traumatic brain injury (TBI). If you have tried antidepressants before without success, this may be a new option to explore.

Minneapolis, Minnesota

Hear when a new Parkinson’s disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.